Investor Relations header Spectrum Pharmaceuticals Investor Relations picture
      
Oncology, Generics, Neurology Drugs About Spectrum Pharmaceuticals SPPI Investor Relations SPPI News
shadow area

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jan 14, 2012 shrotriya rajesh c md Officer Disposition (Non Open Market) 16,848 14.63
Dec 29, 2011 shrotriya rajesh c md Officer Option Execute 205,836 1.43 - 5.53
Dec 23, 2011 scott brett l Officer Acquisition (Non Open Market) 86,500 14.77
Dec 23, 2011 scott brett l Officer Disposition (Non Open Market) 40,179 14.77
Dec 23, 2011 shields james Officer Acquisition (Non Open Market) 86,500 14.77
Dec 23, 2011 shields james Officer Disposition (Non Open Market) 36,719 14.77
Dec 23, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 520,000 14.77
Dec 23, 2011 shrotriya rajesh c md Officer Disposition (Non Open Market) 189,540 14.77
Nov 29, 2011 shields james Officer Acquisition (Non Open Market) 10,000 n/a
Nov 29, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 600,000 n/a
May 13, 2011 maida anthony e iii Director Sell 3,000 7.59
May 13, 2011 maida anthony e iii Director Option Execute 3,000 2.55
Jan 20, 2011 scott brett l Officer Buy 4,000 6.05
Jan 3, 2011 kumaria shyam k Officer Acquisition (Non Open Market) 20,000 n/a
Jan 3, 2011 shields james Officer Acquisition (Non Open Market) 20,000 n/a
Jan 3, 2011 shrotriya rajesh c md Officer Acquisition (Non Open Market) 250,000 n/a
Jan 3, 2011 tidmarsh george f Officer Acquisition (Non Open Market) 20,000 n/a
Dec 23, 2010 shields james Officer Statement of Ownership 0 n/a
Nov 16, 2010 maida anthony e iii Director Sell 5,000 4.46
Nov 16, 2010 maida anthony e iii Director Option Execute 5,000 2.55
Showing 1-20 of 71 transactions Page: 1 2 3 4  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Information
NASDAQ:SPPI
$14.35   + 0.15 		Feb 3, 2012
4:00 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Shareholder Tools

Search Investor Relations



Advanced Search  |  Home  |  Site Map  |  Contact Us  |  WebMail

 All contents © Copyright Spectrum Pharmaceuticals, Inc. 2012. All Rights Reserved.  Terms of Use

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Annual Meeting & Proxy Information
Financial Information
Stock Information
Corporate Presentation
Investor FAQs
Contact Us